Cargando…

Chronic hepatitis E infection with an emerging virus strain in a heart transplant recipient successfully treated with ribavirin: a case report

INTRODUCTION: During the last decade hepatitis E infections have been recognized as a health problem in high-income countries, where hepatitis E virus genotype 3 is endemic. The infection is often self-limiting, but may develop into chronic infection in immunocompromised patients, especially in soli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waldenström, Jesper, Castedal, Maria, Konar, Jan, Karason, Kristjan, Lagging, Martin, Norder, Helene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550050/ https://www.ncbi.nlm.nih.gov/pubmed/26307049 http://dx.doi.org/10.1186/s13256-015-0655-z

Ejemplares similares

Hepatitis E Virus Infection, a Risk for Liver Transplant Recipients in Sweden
por: Frankal, Miriam, et al.
Publicado: (2022)

Inosine Triphosphate Pyrophosphatase Dephosphorylates Ribavirin Triphosphate and Reduced Enzymatic Activity Potentiates Mutagenesis in Hepatitis C Virus
por: Nyström, Kristina, et al.
Publicado: (2018)

No need to discontinue hepatitis C virus therapy at the time of liver transplantation
por: Skoglund, Catarina, et al.
Publicado: (2019)

Randomized Trial Evaluating the Impact of Ribavirin Mono-Therapy and Double Dosing on Viral Kinetics, Ribavirin Pharmacokinetics and Anemia in Hepatitis C Virus Genotype 1 Infection
por: Waldenström, Jesper, et al.
Publicado: (2016)

Successful Outcome of Human Metapneumovirus (hMPV) Pneumonia in a Lung Transplant Recipient Treated With Intravenous Ribavirin
por: Raza, Kashif, et al.
Publicado: (2007)

Haemophagocytic lymphohistiocytosis after heart transplantation: a case report
por: Danielsson, Christian, et al.
Publicado: (2020)

Determining the therapeutic range for ribavirin in transplant recipients with chronic hepatitis E virus infection
por: Mulder, Midas B., et al.
Publicado: (2020)

Clinical features and determinants of VO(2peak) in de novo heart transplant recipients
por: Rolid, Katrine, et al.
Publicado: (2018)

COVID-19 vaccine-induced adverse events predict immunogenicity among recipients of allogeneic hematopoietic stem cell transplantation
por: Wiktorin, Hanna Grauers, et al.
Publicado: (2022)

COVID‐19 in lung transplant recipients: an overview of the Swedish national experience
por: Magnusson, Jesper M., et al.
Publicado: (2021)

Ribavirin as a First Treatment Approach for Hepatitis E Virus Infection in Transplant Recipient Patients
por: Rivero-Juarez, Antonio, et al.
Publicado: (2019)

An HCV‐positive recipient of an HCV‐positive donor liver successfully treated before and immediately after liver transplant with daclatasvir, sofosbuvir, and ribavirin
por: Poordad, Fred, et al.
Publicado: (2017)

Early post-transplant elevated pulmonary artery pressure predicts adverse outcome in cardiac recipients
por: Bollano, Entela, et al.
Publicado: (2019)

Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients
por: Ollivier-Hourmand, I., et al.
Publicado: (2020)

Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection
por: Low, En Xian Sarah, et al.
Publicado: (2019)

Reduced immunogenicity of a third COVID-19 vaccination among recipients of allogeneic hematopoietic stem cell transplantation
por: Einarsdottir, Sigrun, et al.
Publicado: (2022)

Analysis of Multiple Liver Explant Pieces Reveals that Levels of Hepatitis Delta Virus RNA Are Independent of Hepatitis B Virus Expression
por: Prakash, Kasthuri, et al.
Publicado: (2021)

Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report
por: Fraga, Montserrat, et al.
Publicado: (2019)

Treatment of hepatitis C virus infection for adults and children: Updated Swedish consensus recommendations
por: Lagging, Martin, et al.
Publicado: (2016)

The trajectory of renal function following mechanical circulatory support and subsequent heart transplantation
por: Bartfay, Sven‐Erik, et al.
Publicado: (2022)

1600. An Optimal Respiratory Syncytial Virus (RSV) Treatment in Lung Transplant Recipients: Oral Ribavirin, Inhaled Ribavirin, or Conservative Approach
por: Permpalung, Nitipong, et al.
Publicado: (2018)

Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience
por: Waldenström, Jesper, et al.
Publicado: (2016)

Respiratory syncytial virus pneumonia in a LDLT recipient transplanted for COVID 19 precipitated ACLF: Treated with ribavirin and IVIg
por: Kapoor, Sorabh, et al.
Publicado: (2022)

Quantification of Viral RNA in Multiple Pieces of Explant Liver Tissue Shows Distinct Focal Differences in Hepatitis B Infection( )
por: Rydell, Gustaf E, et al.
Publicado: (2021)

Use of Oral Ribavirin for the Treatment of RSV Infections in Hematopoietic Cell Transplant (HCT) Recipients
por: Foolad, Farnaz, et al.
Publicado: (2017)

Hepatitis B Virus Reactivation in Kidney Transplant Recipients Treated With Belatacept
por: Schwarz, Chloë, et al.
Publicado: (2023)

A Case of Acute Hepatitis E Infection in a Patient with Non-Hodgkin Lymphoma Treated Successfully with Ribavirin
por: Haboubi, Hasan N. Y., et al.
Publicado: (2017)

The relation of 25-hydroxy vitamin D concentrations to liver histopathology, seasonality and baseline characteristics in chronic hepatitis C virus genotype 2 or 3 infection
por: Waldenström, Jesper, et al.
Publicado: (2020)

Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin
por: Abbas, Zaigham, et al.
Publicado: (2013)

High-intensity interval training and health-related quality of life in de novo heart transplant recipients – results from a randomized controlled trial
por: Rolid, Katrine, et al.
Publicado: (2020)

Sofosbuvir Add-on to Ribavirin Treatment for Chronic Hepatitis E Virus Infection in Solid Organ Transplant Recipients Does Not Result in Sustained Virological Response
por: van Wezel, E M, et al.
Publicado: (2019)

GH and the cardiovascular system: an update on a topic at heart
por: Isgaard, Jörgen, et al.
Publicado: (2014)

Heart transplantation in patients bridged with mechanical circulatory support: outcome comparison with matched controls
por: Bartfay, Sven‐Erik, et al.
Publicado: (2023)

Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy
por: Pradat, Pierre, et al.
Publicado: (2015)

Successful Treatment of Hepatitis C with Simeprevir, Sofosbuvir, and Ribavirin in an HIV Coinfected Liver Transplant Patient with Advanced Chronic Kidney Disease
por: Maruyama, Anna, et al.
Publicado: (2016)

Fusarium Infection in a Kidney Transplant Recipient Successfully Treated with Voriconazole
por: Alkhunaizi, Ahmed M., et al.
Publicado: (2018)

Inflammatory cardiomyopathies: short- and long-term outcomes after heart transplantation—a protocol for a systematic review and meta-analysis
por: Bobbio, Emanuele, et al.
Publicado: (2020)

2640. Aerosol vs. Oral Ribavirin for the Treatment of Community-Acquired Respiratory Virus Infections in Lung Transplant Recipients
por: Mui, Emily, et al.
Publicado: (2019)

Core mutations, IL28B polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1 infection
por: Alestig, Erik, et al.
Publicado: (2011)

COVID-19 in solid organ transplant recipients: A national cohort study from Sweden
por: Søfteland, John M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jukqogehko8ci9iur3lbquntf4